• A S N Jackson, P Jain, G R Watkins, G A Whitfield, M M Green, J Valle, M B Taylor, C Dickinson, P M Price, and A Saleem.
• Academic Radiation Oncology, The University of Manchester, Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK. Andrewjackson3@nhs.net
• Clin Oncol (R Coll Radiol). 2010 Sep 1; 22 (7): 570-7.

AimsPatients with locally advanced pancreatic cancer (LAPC) are most commonly managed with chemotherapy or concurrent chemoradiotherapy (CRT), which may or may not include non-involved regional lymph nodes in the clinical target volume. We present our results of CRT for LAPC using capecitabine and delivering radiotherapy to a limited radiation field that excluded non-involved regional lymph nodes from the clinical target volume.Materials And MethodsThirty patients were studied. Patients received 50.4 Gy external beam radiotherapy in 28 fractions, delivered to a planning target volume expanded from the primary tumour and involved nodes only. Capecitabine (500-600 mg/m2) was given twice daily continuously during radiotherapy. Toxicity and efficacy data were prospectively collected.ResultsNausea, vomiting and tumour pain were the most common grade 2 toxicities. One patient developed grade 3 nausea. The median time to progression was 8.8 months, with 20% remaining progression free at 1 year. The median overall survival was 9.7 months with a 1 year survival of 30%. Of 21 patients with imaged progression, 13 (62%) progressed systemically, three (14%) had local progression, two (10%) had locoregional progression and three (14%) progressed with both local/locoregional and systemic disease.ConclusionCRT using capecitabine and limited field radiotherapy is a well-tolerated, relatively efficacious treatment for LAPC. The low toxicity and low regional progression rates support the use of limited field radiotherapy, allowing evaluation of this regimen with other anti-cancer agents.Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

33 keywords...

hide…